Midodrine. A review of its therapeutic use in the management of orthostatic hypotension

Drugs and Aging

Volumn 12, Issue 1, 1998, Pages 75-86

  McClellan, Karen J ^a   Wiseman, Lynda R ^a   Wilde, Michelle I ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTENSIVE AGENT; MIDODRINE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;

CHILL; DRUG TOLERABILITY; HUMAN; HYPERTENSION; ORAL DRUG ADMINISTRATION; ORTHOSTATIC HYPOTENSION; PARESTHESIA; PENIS ERECTION; PRIORITY JOURNAL; PRURITUS; REVIEW; SYNCOPE; SYSTOLIC BLOOD PRESSURE; URINE RETENTION; VERTIGO; AGED; DRUG EFFECT; HEMODYNAMICS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADRENERGIC ALPHA-AGONISTS; AGED; HEMODYNAMIC PROCESSES; HUMANS; HYPOTENSION, ORTHOSTATIC; MIDODRINE;

EID: 0031608212     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199812010-00007     Document Type: Review

References (32)

1. McTavish D, Goa K. Midodrine: a review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders. Drugs 1989 Nov; 38: 757-77
2. Mauro VF. Focus on midodrine: an oral peripheral-acting alpha-agonist for the treatment of orthostatic hypotension. Formulary 1997 Mar; 32: 225-31
3. Robertson D, Davis TL. Recent advances in the treatment of orthostatic hypotension. Neurology 1995 Apr; 45 Suppl. 5: S26-32
4. Thulesius O, Gjöres JE, Berlin E. Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins. Eur J Clin Pharmacol 1979; 16: 423-4
5. McElligott MA, Mitchell MC, Kooi AV. Midodrine elevates blood pressure (BP) in patients with neurogenic orthostatic hypotension (OH) but not in healthy individuals [abstract]. 95th Annual Meeting American Society for Clinical Pharmacology and Therapeutics 1994: 201
6. Gilden JL, Kaufmann H. Midodrine therapy in neurogenic orthostatic hypotension. A double-blind placebo controlled study [abstract]. Clin Auton Res 1994 Aug; 4: 203
7. Wright A, Opfer-Gehrking TL, McElligolt MA, et al. Double-blind, randomized dose-response study of midodrine in patients with neurogenic orthostatic hypotension [abstract]. Neurology 1995 Apr; 45 Suppl. 4: A396-397
8. Gilden JL, Berktold P, Larson K, et al. Efficacy of midodrine therapy for neurogenic orthostatic hypotension in diabetic patients [abstract]. Diabetes 1993 May; 42 Suppl. 1: 100A
9. Gilden J, Hassan T, Rodriguez L, et al. Midodrine therapy improves cerebral blood flow in diabetic patients with neurogenic orthostatic hypotension. Diabetes 1997 May; 46 (Abstract book: 57th annual meeting and scientific sessions) Suppl. 1: 127A
10. Lagi A, Bacalli S, Cencetti S, et al. Cerebral autoregulation in orthostatic hypotension: a transcranial Doppler study. Stroke 1994; 25: 1771-5
11. Grobecker VH, Kees F, Linden M, et al. Studies on the bioavailability of midodrine and α-2,5-dimethoxyphenyl-β-amino-ethanol hydrochloride [in German]. Arzneimittel Forschung 1987; 37 (4): 447-50
12. Zachariah PK, Bloedow DC, Moyer TP, et al. Pharmacodynamics of midodrine, an antihypotensive agent. Clin Pharmacol Ther 1986; 39 (5): 586-91
13. Roberts Pharmaceutical Corporation. ProAmatine (midodrine hydrochloride) prescribing information. Eatontown, New Jersey, USA, 1996
14. Low PA, Gilden JL, Freeman R, et al. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension: a randomized, double-blind multicenter study. JAMA 1997 Apr 2; 277: 1046-51
15. Jankovic J, Gilden JL, Hiner BC, et al. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med 1993 Jul; 95: 38-48
16. Axelrod FB, Krey L, Glickstein JS, et al. Preliminary observations on the use of midodrine in treating orthostatic hypotension in familial dysautonomia. J Auton Nerv Syst 1995 Oct 5; 55: 29-35
17. Stumpf JL, Mitrzyk B. Management of orthostatic hypotension. Am J Hosp Pharm 1994 Mar 1; 51: 648-60
18. Robertson D. Mechanisms of orthostatic hypotension. Curr Opin Cardiol 1993; 8 (5): 737-45
19. Mitsky V, Robertson D. Failure of the autonomic nervous system. Compr Ther 1995; 21 (9): 529-34
20. Senard JM, Montastruc JL. Which drug for which orthostatic hypotension? Fundam Clin Pharmacol 1996; 10 (3): 225-33
21. Nagasawa K, Kurihara H, Yamanaka H, et al. Relation of blood pressure circadian rhythm to cardiovascular complaints and orthostatic test results in patients with orthostatic dysregulation -effects of midodrine on blood pressure circadian rhythm. Int Angiol 1993 Jun; 12: 103-9
22. Coniglio S. The use of a new alpha-adrenergic drug in the treatment of essential hypotension: results of a controlled clinical trial. Arch Med Interna 1980; 32: 14-28
23. Engel K, Havelec L, Klausgraber F, et al. Comparative studies and evaluation of the therapeutic usability of midodrin (Gutron) in the hypotensive syndrome. Wien Med Wochenschr 1974; 124: 501-7
24. Kratz, H. Comparative clinical study on an antihypotensive therapy with Gutron and a depot preparation. Dr. Med 1978; 7: 36-8
25. Fouad-Tarazi FM, Okabe M, Goren H. Alpha sympathomimetic treatment of autonomie insufficiency with orthostatic hypotension. Am J Med 1995 Dec; 99: 604-10
26. Gilden JL, Douglas F, Robertson GL. A double-blind controlled evaluation of midodrine vs. ephedrine in elderly patients with neurogenic orthostatic hypotension [abstract]. Clin Auton Res 1993 Jun; 3: 208-9
27. Kaufmann H, Brannan T, Krakoff L, et al. Treatment of orthostatic hypotension due to autonomie failure with a peripheral alpha-adrenergic agonist (midodrine). Neurology 1988 Jun; 38: 951-6
28. Nakayama H, Imamura S-i, Nozawa I, et al. Clinical evaluation ol administration of midodrine in patients with orthostatic dysregulation [in Japanese]. Pract Otol 1996; 89 (11): 1407-13
29. Consensus statement on the definition of orthostatic hypotension, pure autonomie failure, and multiple system atrophy. Journal of the Neurological Sciences 1996 Dec; 144: 218-9
30. Gilden JL. Midodrine in neurogenic orthostatic hypotension. A new treatment. Int Angiol 1993 Jun; 12: 125-31
31. Lipsitz LA. Orthostatic hypotension in the elderly. N Engl J Med 1989; 321 (14): 952-7
32. Sainsbury R. Management of postural hypotension. N Ethicals 1996 May; 33: 49-54